Search

Author/Creator Stadt, Udo zur

1. Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first‐line intensified treatment of pediatric patients with high‐risk acute lymphoblastic leukemia in CoALL08‐09 trial. Issue 12 (21st September 2022)

Authors:
Mezger, Kerstin; Ebert, Sabine; Muhle, Hannah Elisa; Stadt, Udo zur; Borkhardt, Arndt; Dilloo, Dagmar; Faber, Jörg; Feuchtinger, Tobias; Imschweiler, Thomas; Jorch, Norbert; Pekrun, Arnulf; Schmid, Irene; Schramm, Franziska; Zimmermann, Martin; Horstmann, Martin A; Escherich, Gabriele
Journal:
Pediatric blood & cancer
Issue:
Volume 69:Issue 12(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Disease‐causing mutations in the XIAP BIR2 domain impair NOD2‐dependent immune signalling. Issue 8 (1st July 2013)

Authors:
Damgaard, Rune Busk; Fiil, Berthe Katrine; Speckmann, Carsten; Yabal, Monica; Stadt, Udo zur; Bekker‐Jensen, Simon; Jost, Philipp J.; Ehl, Stephan; Mailand, Niels; Gyrd‐Hansen, Mads
Journal:
EMBO molecular medicine
Issue:
Volume 5:Issue 8(2013:Aug.)
Page Start:
1278
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗